Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brexpiprazole (OPC-34712) in schizophrenia (STEP 210)
NCT01649557Phase 2Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Aug 2009
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 2 trial of brexpiprazole orally disintegrating tablet in schizophrenia, sponsored by Otsuka Pharmaceutical Development & Commercialization. Started Aug 2009; status: completed.
02
Drugs
brexpiprazole orally disintegrating tablet
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01649557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01649557.